Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ryan Specialty Holdings (RYAN) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for Ryan Specialty Holdings (RYAN) over the last 6 years, with Q3 2025 value amounting to $14.1 million.

  • Ryan Specialty Holdings' Capital Expenditures rose 9904.23% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.0 million, marking a year-over-year increase of 5637.71%. This contributed to the annual value of $47.0 million for FY2024, which is 5784.86% up from last year.
  • As of Q3 2025, Ryan Specialty Holdings' Capital Expenditures stood at $14.1 million, which was up 9904.23% from $19.8 million recorded in Q2 2025.
  • Over the past 5 years, Ryan Specialty Holdings' Capital Expenditures peaked at $339.2 million during Q3 2021, and registered a low of $1.7 million during Q2 2021.
  • Over the past 5 years, Ryan Specialty Holdings' median Capital Expenditures value was $7.4 million (recorded in 2024), while the average stood at $27.0 million.
  • In the last 5 years, Ryan Specialty Holdings' Capital Expenditures soared by 1228922.57% in 2021 and then plummeted by 9845.85% in 2022.
  • Ryan Specialty Holdings' Capital Expenditures (Quarter) stood at $339.2 million in 2021, then tumbled by 99.11% to $3.0 million in 2022, then soared by 356.18% to $13.8 million in 2023, then rose by 25.67% to $17.3 million in 2024, then decreased by 18.29% to $14.1 million in 2025.
  • Its Capital Expenditures stands at $14.1 million for Q3 2025, versus $19.8 million for Q2 2025 and $16.7 million for Q1 2025.